GPT and fatty liver disease: SAVO largely alleviated HFD‐induced hepatic steatosis, as evidenced by reduced hepatic triacylglycerol (TG) and total cholesterol (TC) levels, and reduced aspartate transferase (AST), alanine transaminase (ALT), TG, and TC levels in serum.